{"transactions":[{"id":2682301,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":138682,"kind":"person","name":"Ebbers Ed","position":1,"cik":"0001643353","reported_name":"Ebbers Ed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, Dermatology"}}],"security":"Common Stock","published_at":"2021-06-03T21:37:09.000Z","date":"2021-06-01","kind":"tax_withholding","acquired":false,"shares":1485,"price":18.76,"value":27858.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the total number of shares withheld by the Company to settle the Reporting Person's minimum tax liability pursuant to the contractual provisions of the June 2018 Restricted Stock Unit grant agreement previously disclosed."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":39300,"source":{"system":"sec-edgar","filing":"0001209191-21-037810","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000120919121037810/doc4.xml","form_type":"4"}},{"id":2772805,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":138682,"kind":"person","name":"Ebbers Ed","position":1,"cik":"0001643353","reported_name":"Ebbers Ed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, Dermatology"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-24T22:17:11.000Z","date":"2021-03-22","kind":"grant","acquired":true,"shares":15875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of March 1, 2021, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":15875,"derivative":{"exercise_price":24.03,"exercise_date":"2022-03-01","expiration_date":"2031-03-22","underlying":"Common Stock","underlying_shares":15875},"source":{"system":"sec-edgar","filing":"0001209191-21-022927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000120919121022927/doc4.xml","form_type":"4"}},{"id":2772804,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":138682,"kind":"person","name":"Ebbers Ed","position":1,"cik":"0001643353","reported_name":"Ebbers Ed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, Dermatology"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-24T22:17:11.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020."}],"balance_after":37500,"derivative":{"exercise_price":10.66,"expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-21-022927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000120919121022927/doc4.xml","form_type":"4"}},{"id":3499935,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":138682,"kind":"person","name":"Ebbers Ed","position":1,"cik":"0001643353","reported_name":"Ebbers Ed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, Dermatology"}}],"security":"Common Stock","published_at":"2019-06-06T01:32:25.000Z","date":"2019-06-03","kind":"tax_withholding","acquired":false,"shares":2671,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reflected on this Form 4 represent shares surrendered exclusively for the payment of tax obligations as set forth in Mr. Ebbers' previously disclosed June 2018 Restricted Stock Unit grant agreement (\"RSU agreement\"). Mr. Ebbers has not sold or in any other way disposed of shares in any manner other than pursuant to the contractual provisions of the RSU agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The market close price of $11.51 per share on June 3, 2019 was used to calculate the number of withheld shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":37932,"source":{"system":"sec-edgar","filing":"0001209191-19-034966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000120919119034966/doc4.xml","form_type":"4"}}]}